Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial.
Yamada H, Deguchi M, Saito S, Takeshita T, Mitsui M, Saito T, Nagamatsu T, Takakuwa K, Nakatsuka M, Yoneda S, Egashira K, Tachibana M, Matsubara K, Honda R, Fukui A, Tanaka K, Sengoku K, Endo T, Yata H. Yamada H, et al. Among authors: nagamatsu t. EClinicalMedicine. 2022 Jun 29;50:101527. doi: 10.1016/j.eclinm.2022.101527. eCollection 2022 Aug. EClinicalMedicine. 2022. PMID: 35795714 Free PMC article.
Newborn Congenital Cytomegalovirus Screening Based on Clinical Manifestations and Evaluation of DNA-based Assays for In Vitro Diagnostics.
Fujii T, Oka A, Morioka I, Moriuchi H, Koyano S, Yamada H, Saito S, Sameshima H, Nagamatsu T, Tsuchida S, Inoue N; Japanese Congenital Cytomegalovirus Study Group. Fujii T, et al. Among authors: nagamatsu t. Pediatr Infect Dis J. 2017 Oct;36(10):942-946. doi: 10.1097/INF.0000000000001630. Pediatr Infect Dis J. 2017. PMID: 28471866
High doses of intravenous immunoglobulin stimulate regulatory T cell and suppress natural killer cell in women with recurrent pregnancy loss.
Yamada H, Deguchi M, Saito S, Takeshita T, Mitsui M, Saito T, Nagamatsu T, Takakuwa K, Nakatsuka M, Yoneda S, Egashira K, Tachibana M, Matsubara K, Honda R, Fukui A, Tanaka K, Sengoku K, Endo T, Yata H. Yamada H, et al. Among authors: nagamatsu t. J Reprod Immunol. 2023 Aug;158:103977. doi: 10.1016/j.jri.2023.103977. Epub 2023 Jun 14. J Reprod Immunol. 2023. PMID: 37354783 Free article. Clinical Trial.
Anti-β2-glycoprotein I/HLA-DR Antibody and Adverse Obstetric Outcomes.
Tanimura K, Saito S, Tsuda S, Ono Y, Ota H, Wada S, Deguchi M, Nakatsuka M, Nagamatsu T, Fujii T, Kobashi G, Arase H, Yamada H. Tanimura K, et al. Among authors: nagamatsu t. Int J Mol Sci. 2023 Jun 30;24(13):10958. doi: 10.3390/ijms241310958. Int J Mol Sci. 2023. PMID: 37446134 Free PMC article.
Fetal cell-free DNA fraction in maternal plasma for the prediction of hypertensive disorders of pregnancy.
Suzumori N, Sekizawa A, Ebara T, Samura O, Sasaki A, Akaishi R, Wada S, Hamanoue H, Hirahara F, Izumi H, Sawai H, Nakamura H, Yamada T, Miura K, Masuzaki H, Yamashita T, Okai T, Kamei Y, Namba A, Murotsuki J, Tanemoto T, Fukushima A, Haino K, Tairaku S, Matsubara K, Maeda K, Kaji T, Ogawa M, Osada H, Nishizawa H, Okamoto Y, Kanagawa T, Kakigano A, Kitagawa M, Ogawa M, Izumi S, Katagiri Y, Takeshita N, Kasai Y, Naruse K, Neki R, Masuyama H, Hyodo M, Kawano Y, Ohba T, Ichizuka K, Nagamatsu T, Watanabe A, Shirato N, Yotsumoto J, Nishiyama M, Hirose T, Sago H. Suzumori N, et al. Among authors: nagamatsu t. Eur J Obstet Gynecol Reprod Biol. 2018 May;224:165-169. doi: 10.1016/j.ejogrb.2018.03.048. Epub 2018 Mar 26. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 29605711
Efficacy and safety of controlled-release dinoprostone vaginal delivery system (PROPESS) in Japanese pregnant women requiring cervical ripening: Results from a multicenter, randomized, double-blind, placebo-controlled phase III study.
Itoh H, Ishii K, Shigeta N, Itakura A, Hamada H, Nagamatsu T, Ishida T, Bungyoku Y, Falahati A, Tomisaka M, Kitamura M. Itoh H, et al. Among authors: nagamatsu t. J Obstet Gynaecol Res. 2021 Jan;47(1):216-225. doi: 10.1111/jog.14472. Epub 2020 Oct 22. J Obstet Gynaecol Res. 2021. PMID: 33094550 Free PMC article. Clinical Trial.
A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing Lactobacillus, GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2).
Ikeda Y, Adachi K, Tomio K, Eguchi-Kojima S, Tsuruga T, Uchino-Mori M, Taguchi A, Komatsu A, Nagamatsu T, Oda K, Kawana-Tachikawa A, Uemura Y, Igimi S, Osuga Y, Fujii T, Kawana K. Ikeda Y, et al. Among authors: nagamatsu t. Vaccines (Basel). 2021 Apr 1;9(4):329. doi: 10.3390/vaccines9040329. Vaccines (Basel). 2021. PMID: 33915901 Free PMC article.
310 results